Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > It will be a jv, not yet a buy out

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Jun 05, 2023 10:29am

224 Views

Post# 35480295

RE:It will be a jv, not yet a buy out

Well said ScienceFirst, I too think its not likely a JV will be announced before Theralase's AGM. I am sure a discussion will occur at the AGM by the company or through the question period by shareholders seeking progress from all highly discussed possible milestones in NMIBC, vaccine/therapeutic , BGM & NSCLC.

This years AGM will be very interesting.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario